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Abstract
Asthma prevalence in children varies substantially around the world, but the contribution of known 
risk factors to this international variation is uncertain.
The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Two studied 8-12 year 
old children in 30 centres worldwide with parent-completed symptom and risk factor questionnaires 
and aeroallergen skin prick testing. We used multilevel logistic regression modelling to investigate 
the effect of adjustment for individual and ecological risk factors on the between-centre variation in 
prevalence of recent wheeze.
Adjustment for single individual-level risk factors changed the centre-level variation from a reduction 
of up to 8% (and 9% for atopy) to an increase of up to 6%. Modelling the 11 most influential 
environmental factors among all children simultaneously, the centre-level variation changed little 
overall (2.4% increase). Modelling only factors that decreased the variance, the 6 most influential 
factors (synthetic and feather quilt, mother's smoking, heating stoves, dampness and foam pillows) 
in combination resulted in a 21% reduction in variance. Ecological (centre-level) risk factors generally 
explained higher proportions of the variation than did individual risk factors.
Single environmental factors and aeroallergen sensitisation measured at the individual (child) level 
did not explain much of the between-centre variation in wheeze prevalence.
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Introduction
Asthma poses an important health burden worldwide, but its aetiology is still not fully understood, 
particularly in low- and middle-income countries. For instance, allergic mechanisms which have been 
widely studied in high-income countries appear to be less important in less affluent settings [1]. 
There are substantial differences in childhood asthma prevalence worldwide [2] as described in 
Phases One and Three of the International Study of Asthma and Allergy in Childhood (ISAAC), which 
are also apparent in ISAAC Phase Two where allergic sensitization was assessed by aeroallergen skin 
prick testing [3]. It is not known how much of this international variation in wheeze prevalence is 
explained by differences in allergic sensitization or other individual-level risk factors. If the currently 
well-established risk factors fail to explain a substantial part of the international variation this would 
indicate that important risk factors are still undiscovered. In addition to these child-level risk factors 
(e.g. the child is vaccinated against measles), contextual factors at the population level (e.g. the 
proportion of the population that is vaccinated against measles), may also be relevant in determining 
prevalence. Additionally, ecological (population-level) analyses may inform about risk factors that 
vary little within a given population but vary markedly in prevalence between different populations, 
e.g. factors related to a "Western" life style. Early attempts to exploit prevalence differences to 
understand the role of individual level risk factors in allergic disease were undertaken in Germany 
and China, by comparing one population with a highly Westernized lifestyle (e.g. West Germany, 
Hong Kong) to a population of the same ethnic background that was much less Westernized (e.g. 
East-Germany, mainland China) [4,5]. The Chinese study concluded that lifestyle and environmental 
risk factors that varied between Hong Kong and mainland China could "explain away" the prevalence 
difference between the two populations. However, such a comparison of only two centres is 
inherently limited in terms of generalizability.
In this paper, we extended this approach to thirty diverse study centres, including the German and 
Chinese centres previously studied, to quantify the extent to which known and suspected individual 
and contextual (ecological) risk factors may explain the observed large international variation in the 
prevalence of wheeze in children using data from ISAAC Phase Two.
METHODS
Study population and fieldwork
The methods of ISAAC Phase Two have been described in detail elsewhere [3]. Briefly, random 
samples of at least 10 schools from defined geographical areas were chosen and children (n>l 000
3
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
per centre) attending classes with a majority of 9-11-year-olds were invited to participate. 
Standardized parental questionnaires were used. In a few centres, skin prick tests and risk factor 
questionnaires were carried out in stratified subsamples targeting 100 children with and without 
wheeze in the past year, respectively (details see Online Resource).
Thirty centres in twenty two countries participated in the questionnaire survey and 29 centres from
21 countries performed the standardized skin prick test.
Outcome:
The main symptom of asthma used in this analysis was "wheeze in the past year". Analyses were also 
carried out separately for wheeze among atopic and among non-atopic children. Children were 
defined as atopic if the skin prick test to any of the six aeroallergens (Dermatophagoides 
pteronyssinus, D. farinae, cat dander, Alternaria tenuis, mixed tree pollen and mixed grass pollen) or 
any other locally tested allergen was positive [1]. The standardized protocol can be found online [6].
Exposures:
The detailed questionnaire for environmental risk factors is available online [6] and covers 
environmental and life style risk factors in the domains of early day exposures, diseases and 
immunizations, the child's home (indoor air, animals and other living conditions), exercise and food. 
The questionnaire enquired "Have you made any changes in your home because your child had 
asthma or allergic problems?", with subsequent specifications which were each answered separately: 
removed pets, stopped or reduced smoking, changed pillows, changed bedding, changed floor 
covering. This helps us to address concerns about reverse causality in this cross-sectional study. We 
compared child-level associations (within-centre) before and after exclusion of those reporting 
changes to the relevant risk factor and present these results in supplementary table E2 on the Online 
Resource
Furthermore, we retrieved potentially relevant ecological variables from publicly available data 
sources (for detailed description see Online Resource). Because many potentially relevant factors are 
not available from such sources we additionally derived, by aggregation, centre-level covariates from 
the questionnaires: from the individual data on risk factors, we constructed ecological variables 
giving the prevalence of the individual risk factor in the centre. - for details see Online Resource. We 
did this for all available risk factors acknowledging that some of the resulting variables may be 
indicators for other centre-level risk factors.
Statistical approach
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In this analysis, we were interested in the variation of wheeze prevalence in this international 
multicentre study that is due to true underlying variation between centres and not to the play of 
chance (sampling error). We also sought to estimate how much of the non-sampling variation could 
be explained by between-centre differences in the prevalence of individual or ecological factors 
associated with wheeze. Within the framework of a multilevel logistic regression analysis with 
individuals as the first level and centres as the second level, the "true" wheeze prevalence for each 
centre is reflected (on a logodds scale) by the random intercept for that centre, and the between- 
centre variation can be summarised by the variance of the distribution of the random intercepts 
(tau2).
When introducing explanatory variables the variance tau2 changes: introducing ecological (centre­
level) variables will always lead to a reduction because only the between-centre variance is affected. 
For individual-level variables, where both the individual-level and centre-level variation are affected, 
a change in tau2 can occur in either direction [7].
In order to reduce the between-centre variation, an individual-level variable must be either a risk 
factor (increasing child's risk of wheezing) and more common in centres with higher prevalence of 
disease, or a protective factor at the individual level and inversely correlated with the prevalence of 
disease at the centre level. There are also cases where a risk factor may be inversely correlated with 
wheeze prevalence at the centre level, or a protective factor may be more common in centres with 
higher prevalence of disease. In those instances, adjustment for the child-level associations in the 
multi-level model will increase (not decrease) the between-centre variation (tau2). Thus, adjustment 
for individual-level variables can either decrease ("explain away") or increase ("accentuate") 
between-centre differences in disease prevalence.
In contrast to continuous outcomes and linear models, the variance at individual level in the logistic 
model is determined by the binomial distribution of the dichotomous outcome and therefore, 
models that differ in explanatory variables cannot be compared directly regarding their coefficients 
and their tau2. To allow a direct comparison, we used a scaling method [8], as described in detail 
elsewhere [7]. Hence we compared the rescaled tau2 of risk factor models to the rescaled tau2 of the 
null model without any explanatory factors.
For some risk factors in some centres, the case-control design gives artificially high intercepts 
because of the stratified subsample is enriched for wheezy children. This was corrected in our multi­
level model by using the appropriate sampling weights for wheezy and non-wheezy children in these 
stratified subsamples [9] (for details see Online Resource).
Construction of models with explanatory variables and determination of the change in tau2
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A detailed description can be found in the Online Resource. In brief, we first tested all individual level 
and ecological variables in single risk factor models i.e. only one explanatory variable was introduced. 
The tau2 of these models was compared to the tau2 of the null model: the relative change (in 
percent) in tau2 with regard to the tau2 of the null model was calculated.
The individual risk factors to be introduced in multivariate models were chosen from the risk factors 
that engendered the greatest change in tau2.From previous work with the ISAAC data we know that 
so far adjustment with potential confounders had very little influence on effect estimates in this 
multicentre international context (see e.g. [10,11])
To avoid important losses in the number of children analysed in the multivariate models, we adopted 
a simple approach to substitute the missing values with mean values (for details see the Online 
Resource). We also performed analyses stratified by atopy because the relevant environmental risk 
factors may differ between atopic and non-atopic children reflecting atopic and non-atopic wheeze 
[1,12].
All analyses were carried out using Stata releases 10 and 14 using gllamm (http://www.gllamm.org). 
The rescaling of coefficients and tau2 was carried out according to a do-file developed by the authors 
and published elsewhere [7].
RESULTS
Up to 53748 children (depending on availability of risk factor information) from 30 centres in 22 
countries were included. The prevalence of wheeze in the past year ("recent wheeze") across the 30 
centres ranged from 0.8% in Pichincha Province, Ecuador to 25.6% in Uruguaiana, Brazil [1]. Only 2% 
of the corresponding between centre variation in prevalence could be attributed to binomial 
sampling error (heterogeneity l2= 98%). When the analysis was stratified by skin prick test positivity, 
the prevalence of recent wheeze among atopic children ranged from 1.1% to 40.5% (I2 = 92%) and 
among non-atopic children from 0.5% to 24.1% (I2 = 98%).
Single risk factor models:
Individual level environmental variables
Table 1 shows the 30 variables ascertained at the individual (child) level that lead to the greatest 
changes in tau2 when included, each in turn, in the two-level model. The maximum decrease of tau2 
that was related to adjustment for a single individual-level variable was 8.4% for use of a synthetic 
quilt at present (Table 1, left side). This risk factor had a wide range of prevalence among centres 
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from 1.9% to 87.9%, and was associated with recent wheeze within centres, with an individual-level 
odds ratio (OR) of 1.33 (95% confidence interval (Cl): 1.09 to 1.61).
Adjustment for 14 other factors (singly) reduced the scaled tau2 by more than 2% each. These 
pertained to bedding, smoking habits of the mother, heating of the home and dampness/mould in 
the living area.
Introducing explanatory individual-level factors into the multi-level model sometimes increased the 
between-centre variation. The variable resulting in the strongest increase in tau2 (by 6.8%) was 
having carpets or rugs in the child's bedroom. This factor had a within-centre OR of 0.78 (95% Cl: 
0.65 to 0.94) and ranged in prevalence among centres from 6.2% to 98%. Adjustment for worm 
infection, whooping cough infection, tuberculosis infection, no pillow use and cooking with 
wood/coal at present, each resulted in an increase of more than 2%.
Changes made because of the asthma or allergy of the child partly influenced the results, depending 
on the risk factor. Table E2 in the Online Resource shows the results for the centres that have asked 
these questions which, depending on the risk factor, encompasses more than half up to most of the 
affluent centres where one would expect changes to occur more often because of the frequency of 
allergies and the higher education regarding allergic disease. The change is most marked for carpets 
and rugs where the OR changes to one. For the other factors small to moderate changes were seen 
which, given the precision of the estimates, are within the limits of chance. In line with this is the fact 
that these small changes occurred in both directions when excluding children with changes e.g. an 
increase in the OR for ETS and a decrease for the mother smoking at present.
Analyses of individual level variables stratified by allergic sensitization
Among participants assessed for allergic sensitization (N=31301), a positive skin prick test was 
associated at the individual level with recent wheeze (OR 3.3, 95%CI: 2.8 to 4.0). Adjustment for this 
measure of atopy, which ranged in prevalence across centres from 1.7% to 45.3%, resulted in a 8.5% 
decrease of between-centre variation in wheeze prevalence.
When restricting the population to atopic children and non-atopic children, respectively, the pattern 
(as shown in Table 2 which contains the same variables as Table 1) only partly corresponded to the 
one for wheeze overall (Table 1). In general, greater changes in tau2 were seen among atopic 
children. While adjustment for synthetic bedding resulted in a higher variance change in atopic 
children compared to non-atopic children, results for feather (quilt and pillow) were inconsistent. 
Restricting to children where no changes in bedding occurred, yielded an increase in the OR related 
to synthetic bedding for atopic children and decrease for non-atopic children. However, the changes 
of the ORs were well within the limits of precision (i.e. the 95%-CI). Maternal smoking, especially in
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pregnancy and at present, seemed to be more influential in non-atopic than in atopic children, in 
terms of the effect of adjustment on between-centre variation.
Regarding infections, the changes in variance observed in all children when adjusting for worm 
infection seemed to be mainly driven by non-atopic children. In contrast, adjustment for whooping 
cough infection and tuberculosis vaccination had a stronger effect among atopic children, with 
increases of variance of 7.5% and 15.8%, respectively. In both subgroups many OR were imprecisely 
estimated so the above observations should be interpreted with caution.
The variables inducing the highest changes in tau2 also differed between atopic and non-atopic 
children (Table E3 in Online Resource which contains the 30 variables that lead to the highest 
changes in atopic and non-atopic children, respectively). In atopic children, the numerically most 
important changes were the increase in variation of 15.8% related to tuberculosis vaccination and 
the decrease in variation of 15.6% related to synthetic bedding at present. Variables that do not 
appear in Table 1 but were of importance among atopic children are the number of all siblings (OR 
1.08, 95%-CI: 1.00 to 1.16; 7.8% increase in tau2), the number of older siblings (OR 1.08, 95%-CI: 1.01 
to 1.15; 4.6% increase in tau2) and measles infection (OR 1.40, 95%-CI: 1.18 to 1.65; 4.4% increase in 
tau2) (Table E3 in Online Resource). Among non-atopic children most of the variables with the 
strongest changes in tau2 related to indoor air quality (smoking, heating and dampness), but also 
included bedding and whooping cough.
Overall, adjustment for the most influential risk factors tended to lead predominantly to a decrease 
in variance of prevalence among non-atopic children.; in atopic children, however, adjustment for 
the most influential risk factors more often resulted in an increase in variance.
Centre/country level variables
Ecological variables introduced into the model generally resulted in markedly higher decreases in 
tau2 than those seen for individual level variables (Table 1 and Online Resource Tables E4 and E5). 
The highest decrease of almost 50% was caused by the centre-level prevalence of contact with a dog 
in the first year of life (Online Resource Table E4). Of the factors in Table 1, the highest decrease was 
related to centre-level prevalences of maternal smoking, heating with wood, use of synthetic quilt 
and tuberculosis vaccination. Ecological factors that appeared to influence notably the wheeze 
prevalence variation, but which were not strongly associated with wheeze at the individual level, 
were contact to animals, bedroom sharing and cooked green vegetables (Online Resource Table E4). 
In comparison with individual level variables, the effect estimates for the centre-level average 
exposures were imprecise due to the limited number of centres (contrasting with the large number 
of children for estimation of within-centre associations with individual risk factors). Given this 
limitation, which also applies to the variables from open access data sources, we chose to put our
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emphasis on an in depth analysis of the individual-level variables and to not pursue the analysis of 
the ecological variables with multivariate model.
Among the ecological variables obtained from open access data sources, the strongest reduction in 
variation of wheeze prevalence was linked to the country-level variables: the proportion of the 
population living in urban areas (32% reduction) and other indicators of affluence such as migration, 
and annual urban population growth (Table E4 in Online Resource). The most important centre-level 
variables were related to temperature variability (inverse association with wheeze) and coastal 
location (positive association with wheeze).
Multivariate models
Given the uncertainty regarding estimation of the effect of centre-level variables, we only introduced 
individual-level variables into the multivariate model. In the model incorporating only variables that 
resulted in a decrease in between centre variation by 1.5% and more, we obtained a 21% reduction 
of the between centre prevalence variance tau2 (Table 3). When risk factors that caused an increase 
in tau2 in the univariate models were also introduced, these factors counteracted the influence of 
factors decreasing tau2 and the resulting overall change was an increase by 2.4%. The resulting 
changes in predicted prevalence (converting centre-specific random intercepts from logodds to 
prevalence) are shown in Figure 1 (for details of the calculation of the predicted prevalence, see 
Online Resource).
In the corresponding models for atopic children, we obtained a decrease of tau2 by 16.8% and an 
increase of 11.6%, respectively. In non-atopic children, both models yielded a decrease in tau2, by 
27% and 16%, respectively.
Among the 30703 children in the multivariate model from 29 centres on whom skin prick tests were 
performed, adjustment for individual environmental factors that decreased tau2 reduced tau2 by 
23%. Adjusting further for atopy (as measured by skin prick test positivity) increased the reduction in 
tau2 to 31%. The corresponding results when all environmental factors (that increased or decreased 
tau2) were included were a 9.3% increase before adjustment for atopy and a 0.4% reduction after 
this adjustment. These tau2 differentials are broadly consistent with the effect of adjustment for 
atopy as a single risk factor (8.5% reduction, see above).
DISCUSSION
To our knowledge this is the first analysis investigating the influence of risk factors on the 
international variation of disease symptoms. Single environmental factors and aeroallergen 
sensitisation (atopy) measured at the individual (child) level each explained less than 10% of the
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between-centre variation in wheeze prevalence", and adjustment for some environmental factors 
accentuated the variation in prevalence. When all the most influential child-level variables were 
modelled together, the variation in prevalence was little changed (2.4% increase without including 
atopy, 0.4% decrease if atopy was included). .
So far attempts to unravel the influence of risk factors on prevalence differences have been limited 
to the comparison of two locations [4,5,13]. Those studies investigated smaller prevalence 
differences of 3.7 vs 1.2% [13], 5.8 vs 3.4% [5] and 27 vs 17% [4]. In the Ethiopian study [13], 
adjusting for housing and mattress material did reduce the magnitude of the OR between rural and 
urban location for wheeze and sensitization to house dust mite. In the Chinese study [5], the factors 
that reduced the difference between mainland China and Hong Kong most were foam pillow, cooking 
with gas, damp housing and raw vegetables. The generalizability of such two centre comparisons is 
uncertain but in our study we could improve this by analysing 30 diverse study centres.
In such a multi-centre study, the variation in disease prevalence between the centres reflects three 
components: sampling variation (the play of chance when recruiting individual children); true (non­
sampling) variation (between children and between centres) which can be explained by measured 
risk factors or protective factors which themselves vary in prevalence among the study centres; and 
true variation between centres which is not (yet) explained. We investigated the changes in this third 
component (unexplained variation between centres) as different combinations of risk factors or 
protective factors were included in a multi-level logistic regression model. In such a model, the 
centre-specific prevalences are reflected by a set of intercepts (log-odds) and the parameter tau2 
measures the variance of these centre-specific intercepts.
The individual level environmental and life style factors that caused the highest and most consistent 
changes in tau2 were factors related to bedding material, indoor air quality, mostly smoking, and 
infectious diseases. However, while centre-level variables always result in a decrease of the variation 
our results illustrate that adjustment for individual risk factors can actually lead to changes in tau2 in 
both directions. Overall, individual risk factors explained only a small to moderate amount of the 
prevalence variation.
Several of the most influential child-level variables leading to changes in tau2 were potentially prone 
to reverse causality, if changes had been made to the home environment following (and due to) the 
onset of asthma or allergy in the child. The bias thereby introduced could be in either direction. For 
instance, avoidance of pets by allergic families would tend to attenuate a harmful association of pets 
with wheeze in the child. In contrast, avoidance of feather bedding following the child's asthma 
diagnosis would accentuate risks associated with synthetic pillows and bedding. Reverse causality is 
less of a concern for exposures in the first year of life, although selective avoidance by allergic 
families could still introduce reverse causality biases. Our analyses restricted to children whose
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parents reported making no such changes are generally reassuring. Except for carpets, the 
associations with the environmental factors were not affected substantially and making this 
allowance for possible reverse causality had less effect than the centre selection in this 
complementary analysis.
Therefore reverse causality does not seem to influence much our broad conclusions regarding the 
amount of centre-level variation that could be explained by the investigated environmental factors 
Nevertheless, these measured factors may actually reflect some other underlying unmeasured 
risk/protective factor. If the "true" determinant is measured imperfectly, the change in tau2 will be 
only partial.
With the cross-sectional design we cannot safely infer causality even for the influential risk factors 
regarding the reduction of tau2. These factors may actually reflect some other underlying 
unmeasured risk/protective factor. Because they therefore measure imperfectly the unmeasured 
factor the reduction in tau2 will be only partial.
A positive skin prick test resulted in the same variance reduction as the most prominent 
environmental risk factor. This occurred despite the fact that non-atopic asthma is important 
worldwide [1] but seems plausible given the strong association of atopy with wheeze within centres 
and the wide range of atopy prevalence across our study centres. In our previous work, we have 
found an attributable fraction of atopy on asthma of 40.7% among the affluent centres and 20.3% 
among the non-affluent centres that already highlighted the importance of atopy on the population 
level especially for the affluent world [1]. Therefore, risk factors influencing strongly the 
development of atopy can also be expected to account for some of the international variation in 
wheeze prevalence, in addition to factors influencing asthma through mechanisms independent of 
allergy.
In our dataset, ecological risk factors had a considerably greater explanatory potential than individual 
risk factors, consistent with findings from social sciences regarding the importance of so-called 
contextual factors. For an epidemiological example, it has been found that the wealth of a 
neighbourhood has an effect on adult asthma prevalence independently of the individual's 
socioeconomic status [14] reducing the between centre variation by 37%. For several risk factors in 
the child's environment one could imagine a similar scenario as children move not only within their 
homes but are in contact with their friends' and extended families' homes and public locations. For 
example, it has been shown that community prevalence of cat keeping is a statistically significant 
determinant of mattress cat allergen levels for non-cat owners [15].
The alternative explanation is that these ecological factors are indicators of different life styles 
between regions of the world, which would be the underlying overall cause. Indeed, Pearce and 
Douwes, in their review, propose that there is a Western "package" of environmental and social
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factors that influence asthma prevalence while there is no known risk factor that would be able to 
explain on its own either prevalence differences between populations or changes observed within 
populations over time [16].
In our analysis, the variance explained by average centre-level exposure was generally not 
diminished when incorporating the corresponding individual-level variable (Online Resource Table 
E6). We therefore interpret these centre-level correlations as an indirect indication of the potential 
role of contextual factors, and/or a surrogate for undiscovered individual-level or population-level 
determinants. A strength of the present analysis is that it is the first multicentre comparison, made 
possible by adapting new methodology (i.e. Bauer's scaling method [8]) and therefore being able to 
compare multilevel logistic regression models that contain different individual risk factors. The study 
involved a large number of children, therefore the power for investigating individual risk factors is 
high.
A limitation of our study is that even 30 centres worldwide represent a relatively small number of 
potential centres especially when investigating centre-level variables and consequently uncertainty 
around the estimates of between-centre variation is high. When looking at the estimates of tau2 and 
its standard error (of the null model), our estimate of 0.32 (SE 0.15) shows similar imprecision to 
some other studies, e.g. 0.052 (SE 0.026) for the variance in psychiatric health care utilization [17] 
(235 neighbourhoods) but higher than in other studies, e.g. the study on asthma prevalence in the 
287 Chicago neighbourhoods (0.14 (SE 0.02) [18]). This calls for caution when gauging the 
quantitative importance of the risk factors and part of the changes observed may well lie within the 
range of uncertainty. To our knowledge, no paper has so far tackled this issue but generally just the 
percentage of change was reported ([14,17,19,20]).
Our approach to handling missing observations was a fairly crude one. Unfortunately, almost none of 
the currently available statistical software offers missing imputation for dichotomous variables in a 
multilevel framework. However, in sensitivity analyses treating several centres with risk factor 
information the same as a centre having no information for risk factors, our method to replace the 
values for all children in the centre with the mean international prevalence proved quite robust i.e. 
comparable to the original results. Overall, substituting the missing values with mean values is a 
conservative approach which is expected to lead to an underestimation of the change in variance.
In conclusion, we found several risk factors, both at the individual level and the centre (population) 
level, that explained part of the large worldwide variation in prevalence of wheeze among children. 
Overall, individual risk factors explained a moderate amount of the variation in this international 
study, the most important remediable exposures being bedding material and maternal smoking. 
Atopy, measured by aeroallergen skin prick tests, also explained a proportion of the worldwide 
variation in wheeze prevalence. Our multi-centre study design overcomes the limitations of two-
12
403 centre comparisons and the multi-level modelling approach permits adjustment for the effect of
404 individual-level risk factors, which are excluded in most conventional ecological (centre-level)
405 analyses.
13
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
Appendix: The ISAAC Phase Two Study group
The ISAAC Phase Two Coordinating and Data Centre: S.K. Weiland ! (Director), G. Buchele,
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Table 1: Wheeze prevalence - change in the between-centre variance tau2 by individual level variables and centre level variables
Individual level variables Centre level variables0
(30 centres; 45297 - 51081 children13) (30 centres; 53748 children01)
Risk factor prevalence range
relative 
change in 
tau2(%)
OR 
(LCL-UCL)
relative 
change in 
tau2(%)
OR per 10% 
increase in risk 
factor 
prevalence 
(LCI-UCI)
centre-level correlation 
between wheeze prevalence 
and risk factor prevalence
1.33 115
Bedding: synthetic quilt (present) 1.9-87.9 -8.4 (1.09-1.61) -23.6 (1.04-1.26) 0.5661
Floor covering: fitted or loose carpets (present) 6.2-98.1 6.8 0.78 (0.65-0.94) -6.6
1.05 
(0.98-1.13) 0.2553
Bedding: synthetic quilt (fy) 2.2-75.2 -6.7 1.28 (1.08-1.53) -21.8
1.15 
(1.04-1.28) 0.5546
Bedding: feather quilt (present) 1.2-61.7 -6.7 0.56(0.47-0.65) -8.2
0.88
(0.76-1.04) -0.2701
Mother smoked during the child's fy of life 0.1-43.8 -5.2 1.23 (1.12-1.36) -32.7
1.27 
(1.11-1.45) 0.6252
Mother smoked during pregnancy 0.2-33.9 -4.8 1.28 (1.13-1.44) -34.4
1.38 
(1.16-1.64) 0.6580
Mother smokes at present 0.1-48.3 -4.1 1.19 (1.07-1.32) -24.1
1.20 
(1.06-1.37) 0.5677
Pillow: feather (present) 0.4-91.9 -3.9 0.60 (0.42-0.85) -3.3
0.95 
(0.86-1.05) -0.2822
Disease: worm infection 2.4-99.9 3.4 1.31 (1.03-1.65) -5.0
0.89 
(0.78-1.02) 0.1963
Disease: whooping cough 0.6-48.9 3.1 1.62(1.46-1.80) -0.8
0.96 
(0.81-1.14) -0.1100
Bedding: feather quilt (fy) 1.2-86.2 -3.0 0.66 (0.58-0.75) -3.2
0.94 
(0.82-1.07) -0.2075
Heating inside home (fy) 0.8-98.5 -2.9 1.18 (1.04-1.35) -5.8
1.05 
(0.97-1.15) 0.2913
Heating: wood (fy) 0.1-79.6 -2.9 1.22 (0.96-1.55) -5.7
1.06
(0.96-1.18) 0.4170
Damp or mould (fy) 6.5-36.7 -2.8 1.65 (1.43-1.89) -5.9
1.24 
(0.89-1.73) 0.4396
Heating inside home (present) 0.8-99.9 -2.6 1.11(1.02-1.21) -9.0
1.06
(0.99-1.14) 0.4308
Heating: wood (present) 0-77.2 -2.6 1.10 -24.4 1.16 0.6639
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(0.90-1.34) (1.05-1.29)
Vaccination: tuberculosis 16.5-99.7 2.4 (0.94-1.21) -21.2 (0.83-0.97) -0.3518
Pillow: no pillow (fy) 2.7-56.1 2.3 0.82 (0.69-0.99) -8.9
1.14 
(0.97-1.34) 0.0979
Pillow: feather (fy) 1.3-75.8 -2.2 0.82(0.71-0.94) -4.4
0.94 
(0.83-1.05) -0.3412
Cooking: coal/wood (present) 0-99.3 2.1 1.21 (1.11-1.31) -2.6
0.94 
(0.84-1.06) 0.1318
Damp or mould (present) 2.2-47.1 -2.1 1.51 (1.29-1.76) -2.6
1.09 
(0.88-1.35) 0.3975
Pillow: synthetic fibre (fy) 1.1-85.4 2.0 1.23 (1.06-1.42) -2.4
0.95
(0.85-1.07) 0.0054
Pillow: foam (fy) 0-79.9 -1.7 1.10 (0.97-1.24) -16.3
1.17 
(1.02-1.33) 0.6186
Cooking: coal/wood (fy) 0-99.2 1.7 1.13 (0.93-1.37) -5.0
0.93
(0.83-1.05) -0.1531
Cooking: electricity (fy) 0.3-99.2 1.5 0.86(0.72-1.03) -0.6
1.01
(0.94-1.09) 0.1574
Heating inside home / Cooking: gas, oil, coal, 
coke, wood (present) 0.8-100 -1.4
1.08
(0.95-1.22) -6.0
1.06
(0.97-1.15) 0.2283
ETS: 10 or more cigarettes 4.5-34.4 -1.3 1.17(1.03-1.32) -12.8
1.33
(1.00-1.77) 0.5051
Air conditioning: present 1.2-95.4 -1.3 0.93(0.85-1.01) -9.3
0.91
(0.82-1.02) -0.4027
Breastfeeding 6 months or more 13.5-99.4 -1.2 0.95(0.86-1.06) -4.4
0.94 
(0.85-1.03) 0.0776
Cooking: gas (fy) 0.5-98.9 -1.1 1.10 (0.95-1.29) -1.8
1.03 
(0.96-1.10) 0.0215
a: This table contains all variables that lead to a change of >1% in tau2 when investigated as individual level variables, b: differences in the number of children relate to 
different numbers of missing values for the respective questions: this is because, in the case of stratified subsamples, we did not impute missing values (details see Online 
Resource); c: each child has the value of the mean exposure for children in its centre, i.e. all children in the same centre have the same contextual exposure; d.: all children 
with information on wheeze got assigned a value; fy = first year of life of the child; ETS = Environmental tobacco smoke;
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Table 2: Wheeze prevalence among atopic and non-atopic children - change in the between-centre variance tau2 by individual level variables3.
Risk factor
Bedding: synthetic quilt (present)
Floor covering: fitted or loose carpets (present)
Bedding: synthetic quilt (fy)
Bedding: feather quilt (present)
Mother smoked during the child's fy of life
Mother smoked during pregnancy
Mother smokes at present
Pillow: feather (present)
Disease: worm infection
Disease: whooping cough
Bedding: feather quilt (fy)
Heating inside home (fy)
Heating: wood (fy)
Damp or mould (fy)
Wheeze among atopies Wheeze among non-atopics
(29 centres; 6390 - 7302 children6)(29 centres; 20335 - 23565 children6)
prevalence 
range
relative 
change in tau2 
(%)
OR 
(LCL-UCL)
prevalence 
range
relative 
change in tau2 
(%)
OR 
(LCL-UCL)
4.0-89.8 -15.6 1.54 (1.25-1.90) 
0.68
(0.56-0.83) 
1.36 
(0.99-1.86) 
0.62 
(0.48-0.80) 
1.20
(1.03-1.39) 
1.27 
(1.01-1.61)
1.16 
(1.03-1.32) 
0.66
(0.39-1.13) 
0.96 
(0.78-1.18) 
1.86
(1.50-2.31) 
0.63 
(0.44-0.90) 
1.36 
(1.09-1.69) 
1.48 
(1.26-1.74) 
1.80 
(1.50-2.16) 
1.17
3.8-88.3 -4.4 1.29 (1.02-1.62)
0.98 
(0.77-1.24) 
1.33 
(0.99-1.78) 
0.62 
(0.49-0.77) 
1.50 
(1.33-1.69) 
1.40 
(1.18-1.66)
1.37 
(1.23-1.52) 
0.81 
(0.62-1.07) 
1.58 
(1.26-1.98) 
1.55 
(1.26-1.90) 
0.68 
(0.43-1.08) 
1.24 
(0.97-1.57) 
1.29 
(0.92-1.82) 
1.62 
(1.29-2.05) 
1.22
3.9-98.5 8.4 6.2-98.2 0.6
0-85.0 -10.8 1.5-74.0 -4.1
0-59.1 -1.1 0.9-61.7 -9.4
0-45.7 -3.0 0.1-45.4 -7.2
0-32.2 -3.8 0.2-35.6 -4.4
0-49.5 -1.9 0.1-50.4 -4.9
0-84.8 -2.3 0.4-93.8 -2.7
2.3-99.4 -0.7 2.8-100.0 1.3
0-44.1 7.5 0.7-45.6 3.6
0-85.9 -2.9 1.0-86.7 -3.7
1.0-98.2 -1.6 0.5-96.3 -3.1
0-80.0 -2.5 0.1-79.2 -2.5
5.6-45.8 -2.7 5.6-38.0 -3.1
1.0-96.6 -1.9 0.6-98.4 -5.0(0.98-1.40) (0.99-1.50)
0-75.0 -5.9 1.30 0-78.1 -4.0 1.24
Heating inside home (present)
Heating: wood (present)
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(1.04-1.64) (0.93-1.65)
Vaccination: tuberculosis 14.3-100.0 15.8 1.47 (1.10-1.98) 16.2-99.7 -2.0
0.92 
(0.65-1.29)
Pillow: no pillow (fy) 0-57.1 2.0 0.89 (0.78-1.02)
1.21
2.6-56.0 1.6
-1.7
0.77 
(0.55-1.07)
0.75Pillow: feather (fy) 1.9-82.1 2.3 (0.58-2.52) 1.1-77.1 (0.42-1.32)
Cooking: coal/wood (present) 0-100.0 1.2 1.22 (0.86-1.74) 0-99.5 0.8
1.39 
(1.18-1.64)
Damp or mould (present) 0-51.9 -2.6 1.61 (1.36-1.90) 1.1-48.1 -2.9
1.41 
(1.09-1.83)
Pillow: synthetic fibre (fy) 0.5-97.0 -0.1 1.02(0.65-1.60) 0.3-85.5 4.6
1.30 
(0.85-1.99)
Pillow: foam (fy) 0-77.2 -1.8 1.11 (0.85-1.44) 0-82.2 -2.0
1.13 
(0.95-1.35)
Cooking: coal/wood (fy) 0-94.4 0.6 1.13 (0.87-1.45) 0-99.2 2.0
1.25 
(0.99-1.57)
Cooking: electricity (fy) 1.0-99.3 3.4 0.74 (0.55-0.99) 0.2-99.2 0.2
0.85 
(0.69-1.06)
Heating inside home / Cooking: gas, oil, coal, 
coke, wood (present) 0-100.0 -3.1
1.25 
(0.99-1.57) 0.9-100.0 -0.2
1.01
(0.89-1.14)
ETS: 10 or more cigarettes 4.5-38.3 -0.1 1.10(0.79-1.53) 4.8-34.5 -2.4
1.28
(1.11-1.48)
Air conditioning: present 0-97.0 -0.4 0.83(0.70-0.98) 0.7-96.9 -2.0
0.91
(0.77-1.06)
Breastfeeding 6 months or more 8.4-100.0 -0.2 0.99(0.81-1.21) 12.6-99.4 -0.3
0.91
(0.82-1.01)
Cooking: gas (fy) 0-99.0 -0.7 1.39 (1.10-1.76) 0.6-98.9 0.7
0.95
(0.82-1.10)
a: This table contains the same variables as Table 1 listing the variables that resulted in the strongest changes of tau2 in the whole population (as opposed to non-atopic or 
atopic children only, which is shown in Table E2 in the Online Resource)b: differences in the number of children relate to different numbers of missing values for the 
respective questions;; fy = first year of life of the child; ETS = Environmental tobacco smoke
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Table 3: Wheeze prevalence - change in the between-centre variance tau2 by individual level variables in 
multivariate models
All children 
(N centres=30,
N children=50,852a)
Atopic children 
(N centres=29, 
N children=7,285a$)
Non-atopic children 
(N centres=29, 
N children=23,418a)
Relative change in Relative change in Relative change in
tau2 (%) tau2(%) tau2 (%)
factors that result in increase or 
decrease in tau2
Bedding: synthetic quilt at present 
add Floor covering: fitted or loose
-8.4 -16.4 -4.3
carpet at present -1.0 -5.2 -6.3
add Bedding: feather quilt at present 
add Mother smoked during first year
-3.7 -3.3 -14.1
of life -8.2 -5.0 -20.0
add Worm infection -4.4 -6.5 -19.0
add Whooping cough -3.3 -4.7 -16.9
add Heating inside home fy -5.7 -4.9 -19.7
add Damp or mould fy -7.9 -5.7 -22.8
add Vaccination: tuberculosis -3.2 4.1 -20.0
add Pillow: no pillow fy -0.9 5.6 -18.2
add Cooking: coal/wood at present 2.3 7.3 -15.3
add Pillow: foam fy 2.2 6.7 -15.7
add Cooking: electricity fy 2.4 11.6 -15.9
only factors that result in a decrease 
in tau2 in all children
Bedding: synthetic quilt at present -8.4 -16.4 -4.3
add Bedding: feather quilt at present 
add Mother smoked during first year
-10.5 -13.4 -12.0
of life -15.0 -15.1 -17.6
add Heating inside home fy -17.2 -15.0 -21.3
add Damp or mould fy -19.0 -15.2 -24.9
add Pillow: foam fy -20.5 -16.8 -26.8
fy: first year of life of the child; for choice of variables for multivariate model see Methods section in the Online 
Resource, a: in the stratified subsamples only children included with risk factor information were included 
resulting in 50852 children (in contrast to the 53748 children who had information on wheeze).
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Figure legend:
Fig.l : Predicted prevalence in the centres in the null model and after incorporating the risk factors - 
for the latter a reference population with risk factor prevalences equal to the arithmetic mean of all 
centres was used. Model with decrease and increase tau2: risk factors are included irrespective of the 
direction of change in the between-centre variance; Model with decrease tau2: only risk factors that 
lead to a reduction in the between-centre variance are included for illustrative purpose, (for detailed 
methods see Online Resource).
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Figure Click here to access/download;Figure;Fig1.pdf ±
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Figure 1: Predicted prevalence in the centres in the null model and after incorporating the risk 
factors. Model with decrease and increase tau: risk factors are included irrespective of the direction 
of change in the between-centre variance; Model with decrease tau: only risk factors that lead to a 
reduction in the between-centre variance are included for illustrative purpose.
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